Last reviewed · How we verify
Cotadutide 300 micrograms
At a glance
| Generic name | Cotadutide 300 micrograms |
|---|---|
| Also known as | MEDI0382 |
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cotadutide 300 micrograms CI brief — competitive landscape report
- Cotadutide 300 micrograms updates RSS · CI watch RSS
- AstraZeneca portfolio CI